FURLAN, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 6.876
AS - Asia 6.808
NA - Nord America 6.203
SA - Sud America 1.426
Continente sconosciuto - Info sul continente non disponibili 498
AF - Africa 132
OC - Oceania 3
Totale 21.946
Nazione #
US - Stati Uniti d'America 5.888
RU - Federazione Russa 4.362
SG - Singapore 2.467
CN - Cina 2.134
BR - Brasile 1.199
HK - Hong Kong 851
IT - Italia 795
VN - Vietnam 537
SE - Svezia 457
FR - Francia 357
BD - Bangladesh 333
DE - Germania 244
GB - Regno Unito 180
CA - Canada 156
IN - India 133
FI - Finlandia 92
AR - Argentina 84
NL - Olanda 84
MX - Messico 82
AT - Austria 66
PL - Polonia 62
ZA - Sudafrica 53
ES - Italia 45
EC - Ecuador 44
TR - Turchia 42
ID - Indonesia 41
IE - Irlanda 41
JP - Giappone 40
IQ - Iraq 34
VE - Venezuela 26
PK - Pakistan 22
SA - Arabia Saudita 22
UA - Ucraina 22
CO - Colombia 20
UZ - Uzbekistan 19
JM - Giamaica 17
MA - Marocco 17
PY - Paraguay 17
MY - Malesia 15
LT - Lituania 14
TN - Tunisia 14
UY - Uruguay 14
IR - Iran 12
NP - Nepal 12
TT - Trinidad e Tobago 12
EG - Egitto 11
KE - Kenya 11
CR - Costa Rica 10
OM - Oman 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CL - Cile 9
KR - Corea 9
SN - Senegal 9
LB - Libano 8
AL - Albania 7
BE - Belgio 7
DZ - Algeria 7
IL - Israele 7
MD - Moldavia 7
NI - Nicaragua 7
RO - Romania 7
BO - Bolivia 6
JO - Giordania 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
HN - Honduras 5
PE - Perù 5
BY - Bielorussia 4
KZ - Kazakistan 4
SV - El Salvador 4
TH - Thailandia 4
AU - Australia 3
BB - Barbados 3
BH - Bahrain 3
CY - Cipro 3
GT - Guatemala 3
KG - Kirghizistan 3
PA - Panama 3
PH - Filippine 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
BS - Bahamas 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
KW - Kuwait 2
LY - Libia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
Totale 21.432
Città #
Singapore 1.112
Moscow 922
Dallas 906
San Jose 850
Hong Kong 837
Ashburn 836
Council Bluffs 412
Shanghai 360
Hefei 313
Lauterbourg 291
Beijing 252
Milan 214
New York 206
Ho Chi Minh City 189
Lawrence 174
Los Angeles 172
Princeton 172
São Paulo 139
Santa Clara 137
Hanoi 115
Nuremberg 75
Rome 72
Orem 65
Boardman 58
Washington 58
Munich 56
Warsaw 56
Helsinki 53
Chennai 51
Brooklyn 47
Montreal 45
Chicago 43
Atlanta 42
Denver 42
London 41
Manchester 38
Dublin 37
Houston 35
Stockholm 34
Amsterdam 33
Phoenix 33
Rio de Janeiro 33
Naples 32
Toronto 31
Da Nang 30
Guangzhou 30
Poplar 30
Tokyo 30
Mexico City 29
Seattle 29
Turku 29
Johannesburg 28
Belo Horizonte 26
Haiphong 25
Omaha 25
Vienna 23
Boston 21
Frankfurt am Main 21
San Francisco 20
The Dalles 20
Buffalo 19
Charlotte 17
Dhaka 17
Querétaro 17
Cesano Boscone 16
Hangzhou 16
Quito 16
Tashkent 16
Curitiba 15
Miami 15
Porto Alegre 15
Shenzhen 15
Ankara 14
Brasília 14
Falkenstein 14
Jacksonville 14
Bologna 13
Campinas 13
Florence 13
Mumbai 13
Salvador 13
Columbus 12
Guarulhos 12
Jeddah 12
Montevideo 12
Baghdad 11
Philadelphia 11
Xi'an 11
Fortaleza 10
Kingston 10
Kunming 10
Osasco 10
Pune 10
Ribeirão Preto 10
Baku 9
Betim 9
Calgary 9
Catania 9
Caxias do Sul 9
City of London 9
Totale 10.645
Nome #
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 196
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach 178
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 176
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 176
The unfolded protein response in amyotrophic later sclerosis: Results of a phase 2 trial 167
Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up 166
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 165
Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study 154
Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome 140
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers 137
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder 127
One-year mental health outcomes in a cohort of COVID-19 survivors 124
Neurofilaments light: Possible biomarker of brain modifications in bipolar disorder 120
A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines 117
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 115
Neuroinflammation in Bipolar Depression 115
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients 112
A model of HTLV-I infection in the SCID mouse 111
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 111
The microrna let-7b-5p is negatively associated with inflammation and disease severity in multiple sclerosis 110
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis 109
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: A 2-year study 109
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 108
Classical and unconventional pathways of vesicular release in microglia 107
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis 107
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 107
Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder 107
INCREASE OF MYELOID MICROVESICLES IN THE CEREBROSPINAL FLUID AS BIOMARKER OF MICROGLIA/MACROPHAGE ACTIVATION IN NEUROLOGICAL DISORDERS 106
Absence of central nervous system pathology in severe combined immunodeficiency mice intraperitoneally injected with peripheral blood lymphocytes from multiple sclerosis patients 106
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 105
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 104
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors 103
Inflammatory Markers Predict Blood Neurofilament Light Chain Levels in Acute COVID-19 Patients 102
Gene and stem cell therapy for autoimmune demyelination 100
A helper dependent adenovirus efficiently delivers bioactive FGF-II to the CNS 99
Activation of invariant NKT cells by alpha GalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma 98
miR-21 sustains CD28 signalling and low-affinity T-cell responses at the expense of self-tolerance 98
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis 97
In vivo fate analysis reveals the multipotent and self-renewal features of embryonic AspM expressing cells 97
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates 97
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 96
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 95
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 95
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 95
Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients 93
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 93
iAstrocytes do not restrain T cell proliferation in vitro 92
A single nucleotide ADA genetic variant is associated to central inflammation and clinical presentation in MS: Implications for cladribine treatment 92
Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs 92
2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis 91
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 90
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease 90
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 90
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 89
Absence of immunoglobulin restriction in tears from multiple sclerosis patients 88
Acid sphingomyelinase activity triggers microparticle release from glial cells 88
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life 88
The impact of storage on extracellular vesicles: A systematic study 87
Intranasal Administration of Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Has Therapeutic Effect in Experimental Autoimmune Encephalomyelitis 87
Dysregulation of MS risk genes and pathways at distinct stages of disease 87
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects 86
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 86
Adenovirus-mediated IL-4 transfer is protective in ischemia/reperfusion brain injury 86
Circulating cytotoxic immune cell composition, activation status and toxins expression associate with white matter microstructure in bipolar disorder 86
Administration of an MCP-1 variant to EAE mice prevents inflammatory cell recruitment and protects from demyelination and axonal loss 85
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup 85
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking 84
Indoleamine 2,3-Dioxygenase Deletion to Modulate Kynurenine Pathway and to Prevent Brain Injury after Cardiac Arrest in Mice 83
Ventilation With Argon Improves Survival With Good Neurological Recovery After Prolonged Untreated Cardiac Arrest in Pigs 83
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 83
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 83
Extracellular Vesicles in Neuroinflammation 82
Extracellular vesicles from adipose mesenchymal stem cells target inflamed lymph nodes in experimental autoimmune encephalomyelitis 82
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis 82
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 81
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 81
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis 81
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 80
Changes in circulating pro-inflammatory lymphocytes and cortical excitability with extended-interval natalizumab dosing in multiple sclerosis 80
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 80
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 80
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis 79
PD-1/PD-L Axis in Neuroinflammation: New Insights 78
ACID SPHINGOMYELINASE TRIGGERS P2X7-INDUCED MICROPARTICLE RELEASE FROM GLIAL CELLS 78
Mir106b-25 and Mir17-92 Are Crucially Involved in the Development of Experimental Neuroinflammation 78
Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss 78
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab 77
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome 77
PD-L2 identifies a novel subpopulation of neutrophils displaying immunoregulatory features in Multiple Sclerosis 77
Association between inflammation and brain microstructure in First Episode Psychosis investigated with DTI 76
Microbiota-produced immune regulatory bile acid metabolites control central nervous system autoimmunity 75
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 74
Acid sphingomyelinase activity triggers microparticle release from glial cells (vol 28, pg 1043, 2009) 74
A Tolerizing mRNA Vaccine against Autoimmunity? 73
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 73
Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-Cd20 Monoclonal Antibodies for Multiple Sclerosis Treatment 73
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression 73
A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking 72
Distinct protein expression networks are activated in microglia cells after stimulation with ifn and il-4 72
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 72
Totale 9.869
Categoria #
all - tutte 125.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.143


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022156 0 4 1 57 14 18 16 5 7 15 7 12
2022/20231.070 398 175 50 6 8 85 37 49 28 24 201 9
2023/2024784 7 44 108 61 103 174 20 62 8 26 34 137
2024/20253.776 376 68 54 94 130 313 499 323 662 576 324 357
2025/202614.700 1.036 1.052 1.091 1.911 1.048 399 1.486 1.110 3.876 735 446 510
2026/20271.370 523 847 0 0 0 0 0 0 0 0 0 0
Totale 21.946